Clinical Trials Market Competition Regulatory Approval Market Launches Clinical Research Oncology Pharmaceutical Research Market Trends Research and Development Regulatory Affairs Biosimilars Alzheimer's Treatment Cancer Treatments FDA Approval Weight-loss Drugs Weight Loss Drugs Drug Screening Cost Analysis Sofpironium Bromide Market Dynamics Market Share Biologics Innovative Treatments Pediatric Medication Clinical Trends Clinical Studies Combination Therapies Biotechnology Preventive Medicine Innovative Therapies Generic Pharmaceuticals Weight Management Regulatory Issues Chemical Entities Phase III Trials Innovation Pipeline Vaccine Development Regulatory Approvals Non-invasive Techniques Personalized Medicine Biopharmaceuticals AI Applications Metabolic Disorders Cellular Biology Regulatory Review Market Entry Strategies Pipeline Expansion HIV Prevention Immuno-Oncology Side Effects AI in Drug Discovery Respiratory Diseases Cell Therapy Antidepressants Clinical Therapies Regulatory Agencies Cancer Therapies FDA Approval Process GLP-1 Candidates Collaboration in Pharma Pipeline Strategies Acquisition Strategies FDA Approvals New Products Psychedelic Research Oral Medications Gene Therapy Larger-Molecule Drugs Injectable Drugs Obesity Drugs Phase 3 Clinical Trials Antiviral Drugs Obesity Treatments GLP-1 Medications FDA Regulations
The sale aims to provide short-term cash to advance clinical programs plus to address debt obligations.
